Skip to main content

FDA recall, , Moderate risk

Elekta Synergy, Harmony, Infinity and Versa HD Linear Accelerators

The digital linear accelerators have a manufacturing issue with electrical grounding.

What happened

Elekta, Inc., of Atlanta, Georgia, recalled its Elekta Synergy, Elekta Harmony, Elekta Infinity, and Versa HD digital linear accelerators due to a manufacturing issue and electrical grounding of systems. The recall began on December 14, 2025, and was added to the FDA's Enforcement Report on January 23, 2026. The products were distributed worldwide.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI is listed.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Elekta Medical Linear Accelerator Elekta Synergy, Elekta Harmony, Elekta Infinity, Versa HD

    UDI-DI
    • 05060191071550
    • 05060191071505
    • 05060191071543
    • 05060191071512
    • 05060191071574
    • 05060191071529
    • 05060191071581
    • 05060191071604
    • 07340201503461

Recall details

Company began the recall
Sold in

Worldwide

Company
Elekta, Inc.Atlanta, Georgia
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
97958
Recall number
Z-1164-2026

All recalls from Elekta, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)